Jiangsu Cowin Biotech Co (SHSE:688426) Other Net Income (Loss) : ¥-0.0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Jiangsu Cowin Biotech Co Other Net Income (Loss)?

Jiangsu Cowin Biotech Co's Other Net Income (Loss) for the three months ended in Sep. 2024 was ¥0.0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.0 Mil.

Jiangsu Cowin Biotech Co's quarterly Other Net Income (Loss) declined from Mar. 2024 (¥0.0 Mil) to Jun. 2024 (¥-0.0 Mil) but then increased from Jun. 2024 (¥-0.0 Mil) to Sep. 2024 (¥0.0 Mil).

Jiangsu Cowin Biotech Co's annual Other Net Income (Loss) increased from Dec. 2021 (¥-0.0 Mil) to Dec. 2022 (¥-0.0 Mil) and increased from Dec. 2022 (¥-0.0 Mil) to Dec. 2023 (¥0.0 Mil).

Jiangsu Cowin Biotech Co Other Net Income (Loss) Historical Data

The historical data trend for Jiangsu Cowin Biotech Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Cowin Biotech Co Other Net Income (Loss) Chart

Jiangsu Cowin Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

Jiangsu Cowin Biotech Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Net Income (Loss)	Get a 7-Day Free Trial													-	-	-	-	-

Jiangsu Cowin Biotech Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.0 Mil.

Jiangsu Cowin Biotech Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Jiangsu Cowin Biotech Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Cowin Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Cowin Biotech Co Ltd (SHSE:688426) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Yaocheng Avenue, 4th Floor, TQB Building, Jiangsu Province, Taizhou, CHN, 225300

Website

https://www.cwbio.com

Jiangsu Cowin Biotech Co Ltd is a national high-tech enterprise with independent intellectual property rights based in the field of life sciences. It provides innovative biological products and services to in vitro diagnostic users. The product line mainly includes molecular diagnostic raw materials enzymes, nucleic acid collection and protection agents, nucleic acid extraction kits, molecular diagnostic detection reagents and others.

Executives

Yin Jian Feng	Director
Zhuang Zhi Hua	Directors, senior managers

Jiangsu Cowin Biotech Co Headlines

No Headlines